Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lutz Weber

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
International Urology and Nephrology|October 12, 2012
Nephron-sparing resection of angiomyolipoma after sirolimus pretreatment in patients with tuberous sclerosisMichael Staehler, Matthias Sauter, Andreas Helck, et al.
Beilstein Journal of Organic Chemistry|January 26, 2019
Synthesis of a tubugi-1-toxin conjugate by a modulizable disulfide linker system with a neuropeptide Y analogue showing selectivity for hY1R-overexpressing tumor cellsRainer Kufka, Robert Rennert, Goran N Kaluđerović, et al.
The Journal of Biological Chemistry|November 6, 2001
The IKK-2/Ikappa Balpha /NF-kappa B pathway plays a key role in the regulation of CCR3 and eotaxin-1 in fibroblasts. A critical link to dermatitis in Ikappa Balpha -deficient miceMargit A Huber, Andrea Denk, Ralf U Peter, et al.
Pediatric Nephrology (Berlin, Germany)|July 20, 2004
Reversible end-stage renal disease in an adolescent patient with methylmalonic aciduriaClaus Peter Schmitt, Otto Mehls, Friedrich K Trefz, et al.
Seminars in Oncology|August 10, 2002
The role of ultrasound in detection and management of regional disease in melanoma patientsChristiane Voit, Alfred Schoengen, Markus Schwürzer-Voit, et al.
Cell Cycle (Georgetown, Tex.)|October 17, 2007
Molecular basis for the inhibition of p53 by MdmxGrzegorz M Popowicz, Anna Czarna, Ulli Rothweiler, et al.
Expert Opinion on Therapeutic Patents|February 5, 2013
Mdm2 and MdmX inhibitors for the treatment of cancer: a patent review (2011-present)Krzysztof Zak, Aleksandra Pecak, Barbara Rys, et al.
Therapeutic Drug Monitoring|May 22, 2002
Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipientsMaria Shipkova, Victor W Armstrong, Lutz Weber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Molecular staging in stage II and III melanoma patients and its effect on long-term survivalChristiane Voit, Martina Kron, Juergen Rademaker, et al.
Journal of Medicinal Chemistry|August 6, 2008
NMR screening for lead compounds using tryptophan-mutated proteinsUlli Rothweiler, Anna Czarna, Lutz Weber, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
International Urology and Nephrology|October 12, 2012
Nephron-sparing resection of angiomyolipoma after sirolimus pretreatment in patients with tuberous sclerosisMichael Staehler, Matthias Sauter, Andreas Helck, et al.
Beilstein Journal of Organic Chemistry|January 26, 2019
Synthesis of a tubugi-1-toxin conjugate by a modulizable disulfide linker system with a neuropeptide Y analogue showing selectivity for hY1R-overexpressing tumor cellsRainer Kufka, Robert Rennert, Goran N Kaluđerović, et al.
The Journal of Biological Chemistry|November 6, 2001
The IKK-2/Ikappa Balpha /NF-kappa B pathway plays a key role in the regulation of CCR3 and eotaxin-1 in fibroblasts. A critical link to dermatitis in Ikappa Balpha -deficient miceMargit A Huber, Andrea Denk, Ralf U Peter, et al.
Pediatric Nephrology (Berlin, Germany)|July 20, 2004
Reversible end-stage renal disease in an adolescent patient with methylmalonic aciduriaClaus Peter Schmitt, Otto Mehls, Friedrich K Trefz, et al.
Seminars in Oncology|August 10, 2002
The role of ultrasound in detection and management of regional disease in melanoma patientsChristiane Voit, Alfred Schoengen, Markus Schwürzer-Voit, et al.
Cell Cycle (Georgetown, Tex.)|October 17, 2007
Molecular basis for the inhibition of p53 by MdmxGrzegorz M Popowicz, Anna Czarna, Ulli Rothweiler, et al.
Expert Opinion on Therapeutic Patents|February 5, 2013
Mdm2 and MdmX inhibitors for the treatment of cancer: a patent review (2011-present)Krzysztof Zak, Aleksandra Pecak, Barbara Rys, et al.
Therapeutic Drug Monitoring|May 22, 2002
Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipientsMaria Shipkova, Victor W Armstrong, Lutz Weber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Molecular staging in stage II and III melanoma patients and its effect on long-term survivalChristiane Voit, Martina Kron, Juergen Rademaker, et al.
Journal of Medicinal Chemistry|August 6, 2008
NMR screening for lead compounds using tryptophan-mutated proteinsUlli Rothweiler, Anna Czarna, Lutz Weber, et al.
Pageof 5